ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab

Ensuring compliance and superior data integrity for pharma and biopharma labs

Agilent Technologies Inc. (NYSE: A) has announced that the Agilent Cary 3500 UV-Vis Spectrophotometer is now compatible with the Agilent OpenLab software suite of products. The Cary 3500 UV-Vis data can now be managed, protected, and stored in a secure central database, helping to meet global regulatory requirements.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211206005192/en/

(Photo: Business Wire)

(Photo: Business Wire)

A pharma lab manager survey indicated that data integrity is a top concern. By offering the Cary 3500 UV-Vis system with OpenLab server software, Agilent minimizes security risks while helping to preserve the integrity of the data for a GMP (good manufacturing practice) lab. This introduction provides the technical controls to acquire, process, report, and store data more securely in labs that must follow compliance guidelines of FDA CFR Part 11, or EU Annex 11, in GMP facilities, reducing the risk of GMP audit findings.

“This solution for the Cary 3500 UV-Vis adds efficiency, making it is easier to collaborate in a distributed environment,” said Geoff Winkett, vice president and general manager of Agilent’s Molecular Spectroscopy Division. He continued, “It also provides a more secure solution where all systems store their data in a central location that’s backed up at the server level.”

The Cary 3500 UV-Vis software is an innovative data system that can simultaneously collect the data from standards and unknowns, automatically generate a calibration curve, and determine sample concentration data in a single measurement—in less than five seconds. This efficient and automated data collection and analysis improves data quality and eliminates variability introduced during the measurement process.

The OpenLab software includes secure database storage for electronic records, complete user administration and access privileges, software licensing, and data security settings—including e-signature workflow and enhanced audit trail review capabilities. The new Cary UV Networked Workstation can be integrated into an OpenLab customer environment, making it easier to maintain multiple systems by connecting them to a single OpenLab Server.

The Cary 3500 is the most recent UV-Vis platform from Agilent. Regular hardware and software releases support this platform as it grows in strategic markets, such as pharma and biopharma. The first software release for regulated customers, Workstation Plus, was well accepted, and this release addresses customers seeking a distributed environment solution. The networked workstation is part of a unified compliance initiative that uses OpenLab software to develop all applications based on common standards.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward advancing the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.